Request for Covid-19 Impact Assessment of this Report
The United States Biopharmaceutical Excipients market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Biopharmaceutical Excipients market, reaching US$ million by the year 2028. As for the Europe Biopharmaceutical Excipients landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Biopharmaceutical Excipients players cover BASF SE, ABITEC Corp, Colorcon, Inc, and DFE Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Biopharmaceutical Excipients market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Solubilizers& Surfactants/Emulsifiers
Polyols
Carbohydrates
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Biopharmaceutical Downstream
Biopharmaceutical Upstream
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
BASF SE
ABITEC Corp
Colorcon, Inc
DFE Pharma
Meggle AG
Pharmonix Biological
Roquette
Sigachi Industries
Signet Chemical Corporation
Spectrum Chemical Manufacturing Corp
SPI Pharma
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biopharmaceutical Excipients Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Biopharmaceutical Excipients by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Biopharmaceutical Excipients by Country/Region, 2017, 2022 & 2028
2.2 Biopharmaceutical Excipients Segment by Type
2.2.1 Solubilizers& Surfactants/Emulsifiers
2.2.2 Polyols
2.2.3 Carbohydrates
2.2.4 Other
2.3 Biopharmaceutical Excipients Sales by Type
2.3.1 Global Biopharmaceutical Excipients Sales Market Share by Type (2017-2022)
2.3.2 Global Biopharmaceutical Excipients Revenue and Market Share by Type (2017-2022)
2.3.3 Global Biopharmaceutical Excipients Sale Price by Type (2017-2022)
2.4 Biopharmaceutical Excipients Segment by Application
2.4.1 Biopharmaceutical Downstream
2.4.2 Biopharmaceutical Upstream
2.5 Biopharmaceutical Excipients Sales by Application
2.5.1 Global Biopharmaceutical Excipients Sale Market Share by Application (2017-2022)
2.5.2 Global Biopharmaceutical Excipients Revenue and Market Share by Application (2017-2022)
2.5.3 Global Biopharmaceutical Excipients Sale Price by Application (2017-2022)
3 Global Biopharmaceutical Excipients by Company
3.1 Global Biopharmaceutical Excipients Breakdown Data by Company
3.1.1 Global Biopharmaceutical Excipients Annual Sales by Company (2020-2022)
3.1.2 Global Biopharmaceutical Excipients Sales Market Share by Company (2020-2022)
3.2 Global Biopharmaceutical Excipients Annual Revenue by Company (2020-2022)
3.2.1 Global Biopharmaceutical Excipients Revenue by Company (2020-2022)
3.2.2 Global Biopharmaceutical Excipients Revenue Market Share by Company (2020-2022)
3.3 Global Biopharmaceutical Excipients Sale Price by Company
3.4 Key Manufacturers Biopharmaceutical Excipients Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biopharmaceutical Excipients Product Location Distribution
3.4.2 Players Biopharmaceutical Excipients Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Biopharmaceutical Excipients by Geographic Region
4.1 World Historic Biopharmaceutical Excipients Market Size by Geographic Region (2017-2022)
4.1.1 Global Biopharmaceutical Excipients Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Biopharmaceutical Excipients Annual Revenue by Geographic Region
4.2 World Historic Biopharmaceutical Excipients Market Size by Country/Region (2017-2022)
4.2.1 Global Biopharmaceutical Excipients Annual Sales by Country/Region (2017-2022)
4.2.2 Global Biopharmaceutical Excipients Annual Revenue by Country/Region
4.3 Americas Biopharmaceutical Excipients Sales Growth
4.4 APAC Biopharmaceutical Excipients Sales Growth
4.5 Europe Biopharmaceutical Excipients Sales Growth
4.6 Middle East & Africa Biopharmaceutical Excipients Sales Growth
5 Americas
5.1 Americas Biopharmaceutical Excipients Sales by Country
5.1.1 Americas Biopharmaceutical Excipients Sales by Country (2017-2022)
5.1.2 Americas Biopharmaceutical Excipients Revenue by Country (2017-2022)
5.2 Americas Biopharmaceutical Excipients Sales by Type
5.3 Americas Biopharmaceutical Excipients Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biopharmaceutical Excipients Sales by Region
6.1.1 APAC Biopharmaceutical Excipients Sales by Region (2017-2022)
6.1.2 APAC Biopharmaceutical Excipients Revenue by Region (2017-2022)
6.2 APAC Biopharmaceutical Excipients Sales by Type
6.3 APAC Biopharmaceutical Excipients Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Biopharmaceutical Excipients by Country
7.1.1 Europe Biopharmaceutical Excipients Sales by Country (2017-2022)
7.1.2 Europe Biopharmaceutical Excipients Revenue by Country (2017-2022)
7.2 Europe Biopharmaceutical Excipients Sales by Type
7.3 Europe Biopharmaceutical Excipients Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biopharmaceutical Excipients by Country
8.1.1 Middle East & Africa Biopharmaceutical Excipients Sales by Country (2017-2022)
8.1.2 Middle East & Africa Biopharmaceutical Excipients Revenue by Country (2017-2022)
8.2 Middle East & Africa Biopharmaceutical Excipients Sales by Type
8.3 Middle East & Africa Biopharmaceutical Excipients Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biopharmaceutical Excipients
10.3 Manufacturing Process Analysis of Biopharmaceutical Excipients
10.4 Industry Chain Structure of Biopharmaceutical Excipients
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biopharmaceutical Excipients Distributors
11.3 Biopharmaceutical Excipients Customer
12 World Forecast Review for Biopharmaceutical Excipients by Geographic Region
12.1 Global Biopharmaceutical Excipients Market Size Forecast by Region
12.1.1 Global Biopharmaceutical Excipients Forecast by Region (2023-2028)
12.1.2 Global Biopharmaceutical Excipients Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Biopharmaceutical Excipients Forecast by Type
12.7 Global Biopharmaceutical Excipients Forecast by Application
13 Key Players Analysis
13.1 BASF SE
13.1.1 BASF SE Company Information
13.1.2 BASF SE Biopharmaceutical Excipients Product Offered
13.1.3 BASF SE Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 BASF SE Main Business Overview
13.1.5 BASF SE Latest Developments
13.2 ABITEC Corp
13.2.1 ABITEC Corp Company Information
13.2.2 ABITEC Corp Biopharmaceutical Excipients Product Offered
13.2.3 ABITEC Corp Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 ABITEC Corp Main Business Overview
13.2.5 ABITEC Corp Latest Developments
13.3 Colorcon, Inc
13.3.1 Colorcon, Inc Company Information
13.3.2 Colorcon, Inc Biopharmaceutical Excipients Product Offered
13.3.3 Colorcon, Inc Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Colorcon, Inc Main Business Overview
13.3.5 Colorcon, Inc Latest Developments
13.4 DFE Pharma
13.4.1 DFE Pharma Company Information
13.4.2 DFE Pharma Biopharmaceutical Excipients Product Offered
13.4.3 DFE Pharma Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 DFE Pharma Main Business Overview
13.4.5 DFE Pharma Latest Developments
13.5 Meggle AG
13.5.1 Meggle AG Company Information
13.5.2 Meggle AG Biopharmaceutical Excipients Product Offered
13.5.3 Meggle AG Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Meggle AG Main Business Overview
13.5.5 Meggle AG Latest Developments
13.6 Pharmonix Biological
13.6.1 Pharmonix Biological Company Information
13.6.2 Pharmonix Biological Biopharmaceutical Excipients Product Offered
13.6.3 Pharmonix Biological Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Pharmonix Biological Main Business Overview
13.6.5 Pharmonix Biological Latest Developments
13.7 Roquette
13.7.1 Roquette Company Information
13.7.2 Roquette Biopharmaceutical Excipients Product Offered
13.7.3 Roquette Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Roquette Main Business Overview
13.7.5 Roquette Latest Developments
13.8 Sigachi Industries
13.8.1 Sigachi Industries Company Information
13.8.2 Sigachi Industries Biopharmaceutical Excipients Product Offered
13.8.3 Sigachi Industries Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Sigachi Industries Main Business Overview
13.8.5 Sigachi Industries Latest Developments
13.9 Signet Chemical Corporation
13.9.1 Signet Chemical Corporation Company Information
13.9.2 Signet Chemical Corporation Biopharmaceutical Excipients Product Offered
13.9.3 Signet Chemical Corporation Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Signet Chemical Corporation Main Business Overview
13.9.5 Signet Chemical Corporation Latest Developments
13.10 Spectrum Chemical Manufacturing Corp
13.10.1 Spectrum Chemical Manufacturing Corp Company Information
13.10.2 Spectrum Chemical Manufacturing Corp Biopharmaceutical Excipients Product Offered
13.10.3 Spectrum Chemical Manufacturing Corp Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Spectrum Chemical Manufacturing Corp Main Business Overview
13.10.5 Spectrum Chemical Manufacturing Corp Latest Developments
13.11 SPI Pharma
13.11.1 SPI Pharma Company Information
13.11.2 SPI Pharma Biopharmaceutical Excipients Product Offered
13.11.3 SPI Pharma Biopharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 SPI Pharma Main Business Overview
13.11.5 SPI Pharma Latest Developments
14 Research Findings and Conclusion
Table 1. Biopharmaceutical Excipients Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Biopharmaceutical Excipients Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Solubilizers& Surfactants/Emulsifiers
Table 4. Major Players of Polyols
Table 5. Major Players of Carbohydrates
Table 6. Major Players of Other
Table 7. Global Biopharmaceutical Excipients Sales by Type (2017-2022) & (K MT)
Table 8. Global Biopharmaceutical Excipients Sales Market Share by Type (2017-2022)
Table 9. Global Biopharmaceutical Excipients Revenue by Type (2017-2022) & ($ million)
Table 10. Global Biopharmaceutical Excipients Revenue Market Share by Type (2017-2022)
Table 11. Global Biopharmaceutical Excipients Sale Price by Type (2017-2022) & (USD/MT)
Table 12. Global Biopharmaceutical Excipients Sales by Application (2017-2022) & (K MT)
Table 13. Global Biopharmaceutical Excipients Sales Market Share by Application (2017-2022)
Table 14. Global Biopharmaceutical Excipients Revenue by Application (2017-2022)
Table 15. Global Biopharmaceutical Excipients Revenue Market Share by Application (2017-2022)
Table 16. Global Biopharmaceutical Excipients Sale Price by Application (2017-2022) & (USD/MT)
Table 17. Global Biopharmaceutical Excipients Sales by Company (2020-2022) & (K MT)
Table 18. Global Biopharmaceutical Excipients Sales Market Share by Company (2020-2022)
Table 19. Global Biopharmaceutical Excipients Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Biopharmaceutical Excipients Revenue Market Share by Company (2020-2022)
Table 21. Global Biopharmaceutical Excipients Sale Price by Company (2020-2022) & (USD/MT)
Table 22. Key Manufacturers Biopharmaceutical Excipients Producing Area Distribution and Sales Area
Table 23. Players Biopharmaceutical Excipients Products Offered
Table 24. Biopharmaceutical Excipients Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Biopharmaceutical Excipients Sales by Geographic Region (2017-2022) & (K MT)
Table 28. Global Biopharmaceutical Excipients Sales Market Share Geographic Region (2017-2022)
Table 29. Global Biopharmaceutical Excipients Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Biopharmaceutical Excipients Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Biopharmaceutical Excipients Sales by Country/Region (2017-2022) & (K MT)
Table 32. Global Biopharmaceutical Excipients Sales Market Share by Country/Region (2017-2022)
Table 33. Global Biopharmaceutical Excipients Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Biopharmaceutical Excipients Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Biopharmaceutical Excipients Sales by Country (2017-2022) & (K MT)
Table 36. Americas Biopharmaceutical Excipients Sales Market Share by Country (2017-2022)
Table 37. Americas Biopharmaceutical Excipients Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Biopharmaceutical Excipients Revenue Market Share by Country (2017-2022)
Table 39. Americas Biopharmaceutical Excipients Sales by Type (2017-2022) & (K MT)
Table 40. Americas Biopharmaceutical Excipients Sales Market Share by Type (2017-2022)
Table 41. Americas Biopharmaceutical Excipients Sales by Application (2017-2022) & (K MT)
Table 42. Americas Biopharmaceutical Excipients Sales Market Share by Application (2017-2022)
Table 43. APAC Biopharmaceutical Excipients Sales by Region (2017-2022) & (K MT)
Table 44. APAC Biopharmaceutical Excipients Sales Market Share by Region (2017-2022)
Table 45. APAC Biopharmaceutical Excipients Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Biopharmaceutical Excipients Revenue Market Share by Region (2017-2022)
Table 47. APAC Biopharmaceutical Excipients Sales by Type (2017-2022) & (K MT)
Table 48. APAC Biopharmaceutical Excipients Sales Market Share by Type (2017-2022)
Table 49. APAC Biopharmaceutical Excipients Sales by Application (2017-2022) & (K MT)
Table 50. APAC Biopharmaceutical Excipients Sales Market Share by Application (2017-2022)
Table 51. Europe Biopharmaceutical Excipients Sales by Country (2017-2022) & (K MT)
Table 52. Europe Biopharmaceutical Excipients Sales Market Share by Country (2017-2022)
Table 53. Europe Biopharmaceutical Excipients Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Biopharmaceutical Excipients Revenue Market Share by Country (2017-2022)
Table 55. Europe Biopharmaceutical Excipients Sales by Type (2017-2022) & (K MT)
Table 56. Europe Biopharmaceutical Excipients Sales Market Share by Type (2017-2022)
Table 57. Europe Biopharmaceutical Excipients Sales by Application (2017-2022) & (K MT)
Table 58. Europe Biopharmaceutical Excipients Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Biopharmaceutical Excipients Sales by Country (2017-2022) & (K MT)
Table 60. Middle East & Africa Biopharmaceutical Excipients Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Biopharmaceutical Excipients Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Biopharmaceutical Excipients Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Biopharmaceutical Excipients Sales by Type (2017-2022) & (K MT)
Table 64. Middle East & Africa Biopharmaceutical Excipients Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Biopharmaceutical Excipients Sales by Application (2017-2022) & (K MT)
Table 66. Middle East & Africa Biopharmaceutical Excipients Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Biopharmaceutical Excipients
Table 68. Key Market Challenges & Risks of Biopharmaceutical Excipients
Table 69. Key Industry Trends of Biopharmaceutical Excipients
Table 70. Biopharmaceutical Excipients Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Biopharmaceutical Excipients Distributors List
Table 73. Biopharmaceutical Excipients Customer List
Table 74. Global Biopharmaceutical Excipients Sales Forecast by Region (2023-2028) & (K MT)
Table 75. Global Biopharmaceutical Excipients Sales Market Forecast by Region
Table 76. Global Biopharmaceutical Excipients Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Biopharmaceutical Excipients Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Biopharmaceutical Excipients Sales Forecast by Country (2023-2028) & (K MT)
Table 79. Americas Biopharmaceutical Excipients Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Biopharmaceutical Excipients Sales Forecast by Region (2023-2028) & (K MT)
Table 81. APAC Biopharmaceutical Excipients Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Biopharmaceutical Excipients Sales Forecast by Country (2023-2028) & (K MT)
Table 83. Europe Biopharmaceutical Excipients Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Biopharmaceutical Excipients Sales Forecast by Country (2023-2028) & (K MT)
Table 85. Middle East & Africa Biopharmaceutical Excipients Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Biopharmaceutical Excipients Sales Forecast by Type (2023-2028) & (K MT)
Table 87. Global Biopharmaceutical Excipients Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Biopharmaceutical Excipients Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Biopharmaceutical Excipients Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Biopharmaceutical Excipients Sales Forecast by Application (2023-2028) & (K MT)
Table 91. Global Biopharmaceutical Excipients Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Biopharmaceutical Excipients Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Biopharmaceutical Excipients Revenue Market Share Forecast by Application (2023-2028)
Table 94. BASF SE Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 95. BASF SE Biopharmaceutical Excipients Product Offered
Table 96. BASF SE Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 97. BASF SE Main Business
Table 98. BASF SE Latest Developments
Table 99. ABITEC Corp Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 100. ABITEC Corp Biopharmaceutical Excipients Product Offered
Table 101. ABITEC Corp Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 102. ABITEC Corp Main Business
Table 103. ABITEC Corp Latest Developments
Table 104. Colorcon, Inc Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 105. Colorcon, Inc Biopharmaceutical Excipients Product Offered
Table 106. Colorcon, Inc Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 107. Colorcon, Inc Main Business
Table 108. Colorcon, Inc Latest Developments
Table 109. DFE Pharma Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 110. DFE Pharma Biopharmaceutical Excipients Product Offered
Table 111. DFE Pharma Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 112. DFE Pharma Main Business
Table 113. DFE Pharma Latest Developments
Table 114. Meggle AG Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 115. Meggle AG Biopharmaceutical Excipients Product Offered
Table 116. Meggle AG Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 117. Meggle AG Main Business
Table 118. Meggle AG Latest Developments
Table 119. Pharmonix Biological Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 120. Pharmonix Biological Biopharmaceutical Excipients Product Offered
Table 121. Pharmonix Biological Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 122. Pharmonix Biological Main Business
Table 123. Pharmonix Biological Latest Developments
Table 124. Roquette Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 125. Roquette Biopharmaceutical Excipients Product Offered
Table 126. Roquette Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 127. Roquette Main Business
Table 128. Roquette Latest Developments
Table 129. Sigachi Industries Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 130. Sigachi Industries Biopharmaceutical Excipients Product Offered
Table 131. Sigachi Industries Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 132. Sigachi Industries Main Business
Table 133. Sigachi Industries Latest Developments
Table 134. Signet Chemical Corporation Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 135. Signet Chemical Corporation Biopharmaceutical Excipients Product Offered
Table 136. Signet Chemical Corporation Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 137. Signet Chemical Corporation Main Business
Table 138. Signet Chemical Corporation Latest Developments
Table 139. Spectrum Chemical Manufacturing Corp Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 140. Spectrum Chemical Manufacturing Corp Biopharmaceutical Excipients Product Offered
Table 141. Spectrum Chemical Manufacturing Corp Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 142. Spectrum Chemical Manufacturing Corp Main Business
Table 143. Spectrum Chemical Manufacturing Corp Latest Developments
Table 144. SPI Pharma Basic Information, Biopharmaceutical Excipients Manufacturing Base, Sales Area and Its Competitors
Table 145. SPI Pharma Biopharmaceutical Excipients Product Offered
Table 146. SPI Pharma Biopharmaceutical Excipients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 147. SPI Pharma Main Business
Table 148. SPI Pharma Latest Developments
List of Figures
Figure 1. Picture of Biopharmaceutical Excipients
Figure 2. Biopharmaceutical Excipients Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biopharmaceutical Excipients Sales Growth Rate 2017-2028 (K MT)
Figure 7. Global Biopharmaceutical Excipients Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Biopharmaceutical Excipients Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Solubilizers& Surfactants/Emulsifiers
Figure 10. Product Picture of Polyols
Figure 11. Product Picture of Carbohydrates
Figure 12. Product Picture of Other
Figure 13. Global Biopharmaceutical Excipients Sales Market Share by Type in 2021
Figure 14. Global Biopharmaceutical Excipients Revenue Market Share by Type (2017-2022)
Figure 15. Biopharmaceutical Excipients Consumed in Biopharmaceutical Downstream
Figure 16. Global Biopharmaceutical Excipients Market: Biopharmaceutical Downstream (2017-2022) & (K MT)
Figure 17. Biopharmaceutical Excipients Consumed in Biopharmaceutical Upstream
Figure 18. Global Biopharmaceutical Excipients Market: Biopharmaceutical Upstream (2017-2022) & (K MT)
Figure 19. Global Biopharmaceutical Excipients Sales Market Share by Application (2017-2022)
Figure 20. Global Biopharmaceutical Excipients Revenue Market Share by Application in 2021
Figure 21. Biopharmaceutical Excipients Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Biopharmaceutical Excipients Revenue Market Share by Company in 2021
Figure 23. Global Biopharmaceutical Excipients Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Biopharmaceutical Excipients Revenue Market Share by Geographic Region in 2021
Figure 25. Global Biopharmaceutical Excipients Sales Market Share by Region (2017-2022)
Figure 26. Global Biopharmaceutical Excipients Revenue Market Share by Country/Region in 2021
Figure 27. Americas Biopharmaceutical Excipients Sales 2017-2022 (K MT)
Figure 28. Americas Biopharmaceutical Excipients Revenue 2017-2022 ($ Millions)
Figure 29. APAC Biopharmaceutical Excipients Sales 2017-2022 (K MT)
Figure 30. APAC Biopharmaceutical Excipients Revenue 2017-2022 ($ Millions)
Figure 31. Europe Biopharmaceutical Excipients Sales 2017-2022 (K MT)
Figure 32. Europe Biopharmaceutical Excipients Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Biopharmaceutical Excipients Sales 2017-2022 (K MT)
Figure 34. Middle East & Africa Biopharmaceutical Excipients Revenue 2017-2022 ($ Millions)
Figure 35. Americas Biopharmaceutical Excipients Sales Market Share by Country in 2021
Figure 36. Americas Biopharmaceutical Excipients Revenue Market Share by Country in 2021
Figure 37. United States Biopharmaceutical Excipients Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Biopharmaceutical Excipients Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Biopharmaceutical Excipients Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Biopharmaceutical Excipients Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Biopharmaceutical Excipients Sales Market Share by Region in 2021
Figure 42. APAC Biopharmaceutical Excipients Revenue Market Share by Regions in 2021
Figure 43. China Biopharmaceutical Excipients Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Biopharmaceutical Excipients Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Biopharmaceutical Excipients Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Biopharmaceutical Excipients Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Biopharmaceutical Excipients Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Biopharmaceutical Excipients Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Biopharmaceutical Excipients Sales Market Share by Country in 2021
Figure 50. Europe Biopharmaceutical Excipients Revenue Market Share by Country in 2021
Figure 51. Germany Biopharmaceutical Excipients Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Biopharmaceutical Excipients Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Biopharmaceutical Excipients Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Biopharmaceutical Excipients Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Biopharmaceutical Excipients Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Biopharmaceutical Excipients Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Biopharmaceutical Excipients Revenue Market Share by Country in 2021
Figure 58. Egypt Biopharmaceutical Excipients Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Biopharmaceutical Excipients Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Biopharmaceutical Excipients Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Biopharmaceutical Excipients Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Biopharmaceutical Excipients Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Biopharmaceutical Excipients in 2021
Figure 64. Manufacturing Process Analysis of Biopharmaceutical Excipients
Figure 65. Industry Chain Structure of Biopharmaceutical Excipients
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...